You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Relapsed/Refractory Peripheral T-cell Lymphoma

Showing 9976 - 10000 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Extensive Stage Small Cell Lung Cancer Trial in France ([177Lu]Lu-DOTA-TATE, Tislelizumab, [68Ga]Ga-DOTA-TATE)

Recruiting
  • Extensive Stage Small Cell Lung Cancer
  • Lille, France
  • +6 more
Jan 23, 2023

NSCLC Trial in Worldwide (Lazertinib 240 mg/160 mg, Gefitinib 250 mg, Lazertinib-matching 240 mg/160 mg)

Active, not recruiting
  • Non-Small Cell Lung Cancer
  • Lazertinib 240 mg/160 mg
  • +3 more
  • Woolloongabba, Queensland, Australia
  • +79 more
Nov 1, 2022

Donor Derived Cell Free DNA and Histopathology in Kidney

Not yet recruiting
  • Transplant;Failure,Kidney
  • +2 more
    • (no location specified)
    Apr 11, 2023

    d To Treat People With Non-Small Cell Lung Cancer

    Recruiting
    • Non-small Cell Lung Cancer (NSCLC)
    • Tokyo, Japan
      Takeda Selected Site
    Oct 13, 2022

    Acute Myelogenous Leukemia Trial in Rochester, Milwaukee (Azacitidine, Venetoclax, Pevonedistat)

    Active, not recruiting
    • Acute Myelogenous Leukemia
    • Rochester, Minnesota
    • +1 more
    Sep 21, 2021

    Non Small Cell Lung Cancer, Nonsquamous Non Small Cell Lung Cancer, Squamous Non-small-cell Lung Cancer Trial in Worldwide

    Recruiting
    • Non Small Cell Lung Cancer
    • +3 more
    • Dhaka, Bangladesh
    • +139 more
    Dec 8, 2022

    IL- 6 Gene Single Nucleotide Polymorphism asIndicator of

    Completed
    • Covid19
    • interleuken 6 level measurment
    • Interleukin-6 Gene-174C detection
    • Tanta, El Gharbyia, Egypt
      Bsant Safwat Kasem
    May 1, 2022

    Vascular Access Trial (Buzzy device plus EMLA cream, Only EMLA cream)

    Not yet recruiting
    • Vascular Access
    • Buzzy device plus EMLA cream
    • Only EMLA cream
    • (no location specified)
    Mar 4, 2022

    Myelofibrosis Trial in Paris (Ruxolotinib)

    Completed
    • Myelofibrosis
    • Paris, France
      ROBIN
    Jul 26, 2022

    Leptomeningeal Metastasis, NSCLC Stage IV, Melanoma Stage IV Trial in Geneva, St Gallen, Zurich (intrathecal nivolumab and

    Recruiting
    • Leptomeningeal Metastasis
    • +2 more
    • intrathecal nivolumab and intrathecal ipilimumab
    • Geneva, Switzerland
    • +2 more
    Dec 18, 2022

    IL-5R Signaling in Non-eosinophil Upper Airway Cells in CRSwNP

    Recruiting
    • Nasal Polyps
    • Aspirin-exacerbated Respiratory Disease
    • Non-Interventional
    • Boston, Massachusetts
      Brigham and Women's Hospital
    Jan 5, 2023

    Patients With Systemic Lupus Erythematosus

    Recruiting
    • Lupus Nephritis
      • Bruxelles, Belgium
        Cliniques universitaires Saint-Luc
      Jun 29, 2022

      NSCLC Metastatic Trial (bevacizumab plus nab-paclitaxel and platinum)

      Not yet recruiting
      • Non-small Cell Lung Cancer Metastatic
      • bevacizumab plus nab-paclitaxel and platinum
      • (no location specified)
      Jun 2, 2022

      Metastatic Colorectal Cancer, Metastatic Colon Cancer Trial in Worldwide (Fruquintinib, Placebo)

      Active, not recruiting
      • Metastatic Colorectal Cancer
      • Metastatic Colon Cancer
      • Phoenix, Arizona
      • +152 more
      Mar 10, 2022

      Anatomic Stage I Breast Cancer AJCC v8, Anatomic Stage II Breast Cancer AJCC v8, Anatomic Stage III Breast Cancer AJCC v8 Trial

      Not yet recruiting
      • Anatomic Stage I Breast Cancer AJCC v8
      • +5 more
      • Atlanta, Georgia
        Emory University Hospital/Winship Cancer Institute
      Jul 14, 2022

      Metastatic Lung Non-Small Cell Carcinoma, Stage IV Lung Cancer AJCC v8, Stage IVA Lung Cancer AJCC v8 Trial (Poziotinib

      Not yet recruiting
      • Metastatic Lung Non-Small Cell Carcinoma
      • +3 more
      • Poziotinib Hydrochloride
      • 1429757-68-5, HM781-36B, NOV-1201 Hydrochloride, NOV120101 Hydrochloride, Poziotinib HCl, POZIOTINIB HYDROCHLORIDE
      • (no location specified)
      Jul 18, 2022

      Vertigo, Dizziness Trial in United States (VRT Care)

      Active, not recruiting
      • Vertigo
      • Dizziness
      • VRT Care
      • Peoria, Illinois
      • +4 more
      Aug 11, 2022

      Sickle Cell Disease Trial in Worldwide (VIT-2763 120 mg, VIT-2763 360 mg, VIT-2763 240 mg)

      Recruiting
      • Sickle Cell Disease
      • VIT-2763 120 mg
      • +4 more
      • Birmingham, Alabama
      • +12 more
      Jan 20, 2023

      Brain Metastases, Renal Cell Carcinoma Trial in Houston (Nivolumab, Ipilimumab, Cabozantinib)

      Not yet recruiting
      • Brain Metastases
      • Renal Cell Carcinoma
      • Houston, Texas
        M D Anderson Cancer Center
      Jul 9, 2022

      Postural Tachycardia Syndrome, Orthostatic Intolerance Trial in Nashville (Carbidopa, Placebo)

      Completed
      Has Results
      • Postural Tachycardia Syndrome
      • Orthostatic Intolerance
      • Nashville, Tennessee
        Vanderbilt University Medical Center
      Jan 14, 2022

      Lung Cancer, Nonsmall Cell Trial in Sacramento ([18F]F-AraG Imaging)

      Enrolling by invitation
      • Lung Cancer, Nonsmall Cell
      • [18F]F-AraG Imaging
      • Sacramento, California
        UC Davis EXPLORER Molecular Imaging Center
      Jan 4, 2023

      Non-small Cell Lung Carcinoma Trial (Pembrolizumab, Paclitaxel, Carboplatin)

      Completed
      Has Results
      • Non-small Cell Lung Carcinoma
      • Pembrolizumab
      • +7 more
      • (no location specified)
      Oct 13, 2022

      Healthy Trial in Rochester (Dasatinib, Quercetin, Fisetin)

      Recruiting
      • Healthy
      • Rochester, Minnesota
        Mayo Clinic in Rochester
      Jul 22, 2022

      Colon Cancer Trial in Slagelse (Metformin Hydrochloride, Placebo oral capsule)

      Completed
      • Colon Cancer
      • Metformin Hydrochloride
      • Placebo oral capsule
      • Slagelse, Denmark
        Department of Surgery, Slagelse Hospital
      Mar 2, 2022

      Chronic Granulomatous Disease X-linked (X-CGD) Trial in Rome, Milan (Ibuprofen, Myelostim, Mozobil)

      Recruiting
      • Chronic Granulomatous Disease X-linked (X-CGD)
      • Rome, Lazio, Italy
      • +1 more
      Oct 27, 2022